iKang Healthcare Group, Inc.
KANG
KANG was delisted on the 18th of January, 2019.
52 hedge funds and large institutions have $370M invested in iKang Healthcare Group, Inc. in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 25 closing their positions.
557% more call options, than puts
Call options by funds: $2.46M | Put options by funds: $374K
17% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 12
17% less funds holding
Funds holding: 63 → 52 (-11)
40% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 25
52% less capital invested
Capital invested by funds: $772M → $370M (-$403M)
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$12.3M |
| 2 |
CFIC
City Financial Investment Company
London,
United Kingdom
|
+$3.57M |
| 3 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$1.59M |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$1.21M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$1.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
Assured Investment Management
New York
|
-$131M |
| 2 |
FTCM
Fir Tree Capital Management
New York
|
-$46.7M |
| 3 |
AC
Athos Capital
Hong Kong
|
-$39.9M |
| 4 |
MCP
Maso Capital Partners
Hong Kong
|
-$39.1M |
| 5 |
Millennium Management
New York
|
-$24.7M |
KANG Hedge Fund Activity: Q3 2018 in Review
52 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in iKang Healthcare Group, Inc. (KANG) for Q3 2018, worth a combined $370M — down 52% from $772M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of KANG and 15 opened new positions — a net loss of 10 holders — while 12 trimmed existing stakes and 14 added.
The largest buyer was State Street, adding an estimated $12.3M. The largest seller was Assured Investment Management, exiting entirely with an estimated $131M sold.
- 52 institutional investors held iKang Healthcare Group, Inc. (KANG) as of Q3 2018, down from 63 in Q2 2018.
- Funds reported $370M of iKang Healthcare Group, Inc. stock for Q3 2018, down 52% quarter-over-quarter.
- 15 funds opened new iKang Healthcare Group, Inc. positions in Q3 2018 and 25 closed out, a net change of -10 holders.
- The largest iKang Healthcare Group, Inc. buyer in Q3 2018 was State Street, an estimated $12.3M added.
- The largest iKang Healthcare Group, Inc. seller in Q3 2018 was Assured Investment Management, an estimated $131M sold.
Based on aggregated 13F filings for Q3 2018.